Elevated serum levels of IL-6 have been associated with increased tumour burden and more advanced disease in several cancer types including colorectal (Belluco et al, 2000), ovarian (Berek et al, 1991) and breast (Zhang and Adachi, 1999; Bachelot et al, 2003). This evidence concerns the gene IL6 and neoplasm.